Skip to content

13F-HR filed by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-13, with 56 holding rows worth $209,600,000.

Accession
0001398344-17-001862
Filed
2017-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 56 entries on the cover page, a total value of $209,600,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $209,603,000 with VALUE read as thousands by filing date, 13F file number 028-15679. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR464287556ISHARES BIOTECH35,000$9,288,000thousands by filing date
HUMANA INC COM444859102Stock38,382$7,831,000thousands by filing date
CELGENE CORP151020104COM67,500$7,813,000thousands by filing date
AETNA INC NEW00817Y108COM60,000$7,441,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR270,000$7,376,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM60,000$7,341,000thousands by filing date
Bristol-Myers Squibb Company110122108COM125,000$7,305,000thousands by filing date
UnitedHealth Group Inc91324P102COM45,000$7,202,000thousands by filing date
Elevance Health, Inc.036752103COM50,000$7,189,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock125,000$7,064,000thousands by filing date
Merck & Co.,Inc.58933Y105COM115,000$6,770,000thousands by filing date
CIGNA CORPORATION125509109COM50,010$6,671,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock17,500$6,424,000thousands by filing date
Gilead Sciences,Inc.375558103COM80,000$5,729,000thousands by filing date
BIOGEN INC COM09062X103Stock20,000$5,672,000thousands by filing date
INCYTE CORP COM45337C102Stock55,000$5,515,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM40,000$5,483,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM60,000$4,970,000thousands by filing date
MCKESSON CORP COM58155Q103Stock35,000$4,916,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM90,000$4,883,000thousands by filing date
BARD C R INC067383109COM20,000$4,493,000thousands by filing date
BECTON DICKINSON & CO075887109COM25,000$4,139,000thousands by filing date
Johnson & Johnson478160104COM35,000$4,032,000thousands by filing date
CENCORA INC COM03073E105Stock50,000$3,910,000thousands by filing date
Boston Scientific Corporation101137107COM175,000$3,785,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock35,000$3,723,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS27,700$3,095,000thousands by filing date
SCHEIN HENRY INC806407102COM19,902$3,019,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM40,000$2,947,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM20,000$2,822,000thousands by filing date
RESMED INC COM761152107Stock45,000$2,792,000thousands by filing date
VWR CORP91843L103COM110,000$2,753,000thousands by filing date
SMITH & NEPHEW PLC SPDN ADR NEW83175M205ADR85,000$2,557,000thousands by filing date
CHEMED CORP NEW16359R103COM15,000$2,406,000thousands by filing date
IDEXX LABS INC COM45168D104Stock20,000$2,345,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM40,000$2,309,000thousands by filing date
Eli Lilly and Company532457108COM30,000$2,207,000thousands by filing date
VCA ANTECH INC918194101COM30,000$2,060,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM70,000$2,019,000thousands by filing date
PAREXEL INTL CORP699462107COM30,000$1,972,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM3,000$1,903,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS70,000$1,609,000thousands by filing date
HOLOGIC INC436440101COM40,000$1,605,000thousands by filing date
LHC GROUP50187A107COM35,000$1,600,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock35,000$1,595,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock15,000$1,406,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM105,000$1,391,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM20,000$1,021,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM25,000$968,000thousands by filing date
BLUEBIRD BIO INC09609G100COM15,000$926,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK30,000$921,000thousands by filing date
AMEDISYS INC023436108COM21,510$917,000thousands by filing date
KITE PHARMA INC49803L109COM18,000$807,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM15,000$666,000thousands by filing date
BAXTER INTL INC071813109COM0$0thousands by filing dateValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.
SEATTLE GENETICS INC812578102COM0$0thousands by filing dateValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-17-001862this filing2017-02-13acceptance time not in the bulk data set